© kentoh Electronics Production | September 05, 2016

Insulet updates materials supplier deal with Flextronics

Flextronics Medical Sales and Marketing has entered into a materials supplier agreement with Insulet.
Under the new agreement, which has an initial term of five years, Flextronics will continue to produce and manufacture the company’s proprietary Omnipod Insulin Management System, as well as the Insulet’s drug delivery devices and personal diabetes managers (PDMs).

Manufacturing by Flextronics of the devices will continue to be done at a facility in China owned and operated by a subsidiary of Flextronics, according to a SEC-filing made by Insulet.


Please note the following: Critical comments are allowed and even encouraged. Discussions are welcome. Verbal abuse, insults and racist / homophobic remarks are not. Such comments will be removed.
Further details can be found here.
Load more news
August 13 2017 4:10 PM V8.5.9-1